The aim of this study was to systematically identify possible hierarchical regulatory role of inflammasome components, including NLRP3 and NLRP1, and the activation of the Th-17 pathway in the luteolin- and wedelolactone-mediated suppression of DSS-induced colitis. This evidence concerns the gene NLRP3 and colitis.